Setiawan Veronica Wendy, Stram Daniel O, Porcel Jacqueline, Lu Shelly C, Le Marchand Loïc, Noureddin Mazen
Department of Preventive Medicine, Keck School of Medicine of University of Southern California, Los Angeles, CA.
Norris Comprehensive Cancer Center, Keck School of Medicine of University of Southern California, Los Angeles, CA.
Hepatology. 2016 Dec;64(6):1969-1977. doi: 10.1002/hep.28677. Epub 2016 Jul 17.
Chronic liver disease (CLD) and cirrhosis are major sources of morbidity and mortality in the United States. Little is known about the epidemiology of these two diseases in ethnic minority populations in the United States. We examined the prevalence of CLD and cirrhosis by underlying etiologies among African Americans, Native Hawaiians, Japanese Americans, Latinos, and whites in the Multiethnic Cohort. CLD and cirrhosis cases were identified using Medicare claims between 1999 and 2012 among the fee-for-service participants (n = 106,458). We used International Classification of Diseases Ninth Revision codes, body mass index, history of diabetes mellitus, and alcohol consumption from questionnaires to identify underlying etiologies. A total of 5,783 CLD (3,575 CLD without cirrhosis and 2,208 cirrhosis) cases were identified. The prevalence of CLD ranged from 3.9% in African Americans and Native Hawaiians to 4.1% in whites, 6.7% in Latinos, and 6.9% in Japanese. Nonalcoholic fatty liver disease (NAFLD) was the most common cause of CLD in all ethnic groups combined (52%), followed by alcoholic liver disease (21%). NAFLD was the most common cause of cirrhosis in the entire cohort. By ethnicity, NAFLD was the most common cause of cirrhosis in Japanese Americans, Native Hawaiians, and Latinos, accounting for 32% of cases. Alcoholic liver disease was the most common cause of cirrhosis in whites (38.2%), while hepatitis C virus was the most common cause in African Americans (29.8%).
We showed racial/ethnic variations in the prevalence of CLD and cirrhosis by underlying etiology; NAFLD was the most common cause of CLD and cirrhosis in the entire cohort, and the high prevalence of NAFLD among Japanese Americans and Native Hawaiians is a novel finding, warranting further studies to elucidate the causes. (Hepatology 2016;64:1969-1977).
慢性肝病(CLD)和肝硬化是美国发病和死亡的主要原因。对于这两种疾病在美国少数族裔人群中的流行病学情况,人们了解甚少。我们在多族裔队列研究中,按潜在病因调查了非裔美国人、夏威夷原住民、日裔美国人、拉丁裔和白人中CLD和肝硬化的患病率。1999年至2012年间,在按服务收费的参与者(n = 106,458)中,通过医疗保险理赔记录确定CLD和肝硬化病例。我们使用国际疾病分类第九版编码、体重指数、糖尿病病史以及问卷中的饮酒情况来确定潜在病因。共识别出5783例CLD病例(3575例无肝硬化的CLD和2208例肝硬化)。CLD的患病率在非裔美国人和夏威夷原住民中为3.9%,白人为4.1%,拉丁裔为6.7%,日裔为6.9%。在所有族裔群体中,非酒精性脂肪性肝病(NAFLD)是CLD最常见的病因(52%),其次是酒精性肝病(21%)。NAFLD是整个队列中肝硬化最常见的病因。按种族划分,NAFLD是日裔美国人、夏威夷原住民和拉丁裔肝硬化最常见的病因,占病例的32%。酒精性肝病是白人肝硬化最常见的病因(38.2%),而丙型肝炎病毒是非洲裔美国人肝硬化最常见的病因(29.8%)。
我们发现按潜在病因划分的CLD和肝硬化患病率存在种族/族裔差异;NAFLD是整个队列中CLD和肝硬化最常见的病因,日裔美国人和夏威夷原住民中NAFLD的高患病率是一个新发现,值得进一步研究以阐明其原因。(《肝脏病学》2016年;64:1969 - 1977)